⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL23357882 | 0.97 | TDP1 (0.38) | — | |
| SCHEMBL893034 | 0.83 | — | — | |
| SCHEMBL1858816 | 0.79 | FFAR3 (0.36) | — | |
| SCHEMBL14055633 | 0.79 | FFAR3 (0.36) | — | |
| SCHEMBL7695769 | 0.78 | — | — | |
| SCHEMBL10044465 | 0.78 | — | — | |
| SCHEMBL17935549 | 0.77 | MAOB (0.41) | — | |
| SCHEMBL294067 | 0.77 | MAOB (0.41) | — | |
| SCHEMBL18229248 | 0.77 | FFAR3 (0.35) | — | |
| Hydrochloric Acid SCHEMBL109328 | 0.77 | FFAR3 (0.35) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 83 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6984754-B1 | Aliphatic amino carboxylic and amino phosphonic acids amino nitriles and amino tetrazoles as cellular rescue agents | UNIVERSITY OF SASKATCHEWAN TECHNOLOGIES INC. (CA) | 2006-01-10 | — | — | US | claimed |
| JP-2002507591-A | — | — | 2002-03-12 | — | — | JP | claimed |
| EP-1064254-A2 | ALIPHATIC AMINO CARBOXYLIC AND AMINO PHOSPHONIC ACIDS, AMINO NITRILES AND AMINO TETRAZOLES AS CELLULAR RESCUE AGENTS | University of Saskatchewan Technologies Inc. (CA) | 2001-01-03 | — | — | EP | claimed |
| WO-1999048858-A2 | ALIPHATIC AMINO CARBOXYLIC AND AMINO PHOSPHONIC ACIDS, AMINO NITRILES AND AMINO TETRAZOLES AS CELLULAR RESCUE AGENTS | UNIVERSITY OF SASKATCHEWAN TECHNOLOGIES INC. (CA) | 1999-09-30 | — | — | WO | claimed |
| EP-3966226-B1 | MASP INHIBITORY COMPOUNDS AND USES THEREOF | BAYER AG (DE) | 2025-12-24 | — | — | EP | disclosed |
| US-12503491-B2 | MASP inhibitory compounds and uses thereof | BAYER AKTIENGESELLSCHAFT (DE) | 2025-12-23 | — | — | US | disclosed |
| CN-114585637-B | MASP-inhibitory compounds and uses thereof | 拜耳公司 | 2025-04-15 | — | — | CN | disclosed |
| US-20240124522-A1 | MASP INHIBITORY COMPOUNDS AND USES THEREOF | BAYER AKTIENGESELLSCHAFT (DE) | 2024-04-18 | — | — | US | disclosed |
| US-11873291-B2 | Quinoline cGAS antagonist compounds | IMMUNESENSOR THERAPEUTICS, INC. (US) | 2024-01-16 | — | — | US | disclosed |
| US-20230322731-A1 | HETEROARYL-BIPHENYL AMIDES FOR THE TREATMENT OF PD-L1 DISEASES | CHEMOCENTRYX, INC. | 2023-10-12 | — | — | US | disclosed |
| US-11760762-B2 | Thienopyranones and furanopyranones as kinase, bromodomain, and checkpoint inhibitors | SIGNALRX PHARMACEUTICALS, INC. (US) | 2023-09-19 | — | — | US | disclosed |
| US-11713307-B2 | Heteroaryl-biphenyl amides for the treatment of PD-L1 diseases | CHEMOCENTRYX, INC. (US) | 2023-08-01 | — | — | US | disclosed |
| CN-1105353-A | Modular design and synthesis of oxazolone-derived molecules | ARQULE PARTNERS L P (US) | 1995-07-19 | — | — | CN | disclosed |
| WO-1995017903-A1 | MODULAR DESIGN AND SYNTHESIS OF OXAZOLONE-DERIVED MOLECULES | ARQULE PARTNERS, L.P. (US) | 1995-07-06 | — | — | WO | disclosed |
| EP-0649443-A1 | OXAZOLONE DERIVED MATERIALS | LEGOMER PARTNERS, L.P. (US) | 1995-04-26 | — | — | EP | disclosed |
| WO-1994000509-A9 | OXAZOLONE DERIVED MATERIALS | — | 1994-03-17 | — | — | WO | disclosed |
| WO-1994000509-A1 | OXAZOLONE DERIVED MATERIALS | LEGOMER PARTNERS, L.P. (US) | 1994-01-06 | — | — | WO | disclosed |
| US-4804500-A | Amine dealkylation process | MONSANTO COMPANY (US) | 1989-02-14 | — | — | US | disclosed |
| EP-0199702-B1 | AMINE DEALKYLATION PROCESS | Monsanto Company (US) | 1988-12-21 | — | — | EP | disclosed |
| EP-0199702-A1 | Amine dealkylation process | Monsanto Company (US) | 1986-10-29 | — | — | EP | disclosed |